Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Nippon Steel discloses anticoagulant, antithrombotic peptide

May 10, 1996

Reteplase multiple boluses claimed for thromboembolic conditions

May 3, 1996

PS-028: Fibrinogen antagonist from Taisho

May 3, 1996

Fuji Pharm. reports new antiplatelet agent

May 3, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Genelabs develops two oral antithrombotics

April 26, 1996

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

More antiplatelet agents from Thomae

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.